Literature DB >> 22045470

Implications of changes in plasma asymmetric dimethylarginine during treatment of hypertension.

Bertrand N Mukete1, Steven A Atlas.   

Abstract

Entities:  

Year:  2011        PMID： 22045470     DOI： 10.1007/s11906-011-0233-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  9 in total

Review 1.  Role of the augmentation index in hypertension.

Authors:  Motohiro Shimizu; Kazuomi Kario
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-02

2.  Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography.

Authors:  Asife Sahinarslan; Atiye Cengel; Gursel Biberoglu; Alev Hasanoglu; Sedat Turkoglu; Timur Timurkaynak
Journal:  Coron Artery Dis       Date:  2006-11       Impact factor: 1.439

Review 3.  Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.

Authors:  C J de Souza; B F Burkey
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

4.  Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone.

Authors:  Janos Toth; Anita Racz; Pawel M Kaminski; Michael S Wolin; Zsolt Bagi; Akos Koller
Journal:  Hypertension       Date:  2007-01-22       Impact factor: 10.190

5.  Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.

Authors:  Tse-Min Lu; Ming-Yi Chung; Ming-Wei Lin; Chiao-Po Hsu; Shing-Jong Lin
Journal:  Int J Cardiol       Date:  2011-07-26       Impact factor: 4.164

6.  Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

Authors:  Ulisse Garbin; Anna Fratta Pasini; Chiara Stranieri; Stefania Manfro; Veronica Boccioletti; Luciano Cominacini
Journal:  Pharmacol Res       Date:  2007-09-26       Impact factor: 7.658

7.  Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.

Authors:  Aytekin Oğuz; Mehmet Uzunlulu; Elif Yorulmaz; Yavuz Yalçin; Nezih Hekim; Francesco Fici
Journal:  Anadolu Kardiyol Derg       Date:  2007-12

Review 8.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

9.  Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.

Authors:  R J MacAllister; S A Fickling; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.